SC
Syno Capital invests in and helps develop healthcare and biotechnology companies.
Synthesis Capital Management invests in early-stage healthcare and medtech ventures across Asia-Pacific.
Synthesis Capital Management is an Australian venture capital firm focused on healthcare innovation across Asia-Pacific. It invests from pre-seed through Series A and beyond, providing staged capital linked to development milestones.
Its investment interests include medtech, biotechnology, digital health, technologies that expand human capability, early-life health, longevity and social care. The firm partners with MedTech Actuator to support the development and commercialisation of healthcare ventures.